Evidence map›Paper›PMID 39571835›Full record

ArticleAmerican journal of preventive medicine2025

Quit Attempts and Use of Cessation Aids Among U.S. Adults Who Smoke Nondaily.

Daniela S Gutiérrez-Torres, Carolyn Reyes-Guzman, Margaret Mayer, Yvonne M Prutzman, Neal D Freedman

Abstract read
In one paragraph

Article in American journal of preventive medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Daniela S Gutiérrez-TorresMetabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland. Electronic address: danielasarahi.gutierreztorres@nih.gov.
Carolyn Reyes-GuzmanTobacco Control Research Branch, Behavioral Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Rockville, Maryland.
Margaret MayerTobacco Control Research Branch, Behavioral Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Rockville, Maryland.
Yvonne M PrutzmanTobacco Control Research Branch, Behavioral Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Rockville, Maryland.
Neal D FreedmanTobacco Control Research Branch, Behavioral Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Rockville, Maryland.

Funding

Upper Gastrointestinal Cancer StudiesZIACP000185 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI ABNET, CHRISTIAN · 2009 to 2025
$25.6M
Intramural NIH HHS ZIA CP000185
6 · The paper itself

Abstract

introductionAbout 25% of people who currently smoke cigarettes in the U.S. smoke nondaily, and relatively little is known about their intentions or attempts to quit. Active surveillance is essential to identify services needed to support smoking cessation efforts and reduce the burden of disease.

methodsU.S. population-wide estimates of quit attempts and use of cessation aids among adults who smoke cigarettes were calculated using data from the September 2022 wave of the Tobacco Use Supplement to the Current Population Survey. Statistical analyses were conducted in 2024. Weighted percentages and 95% CIs are presented by sociodemographic characteristics and smoking pattern.

resultsIn 2022, nearly 6 million adults (2.59 million women, 3.36 million men) in the U.S. reported smoking nondaily an average of 13.4 days per month (95% CI=12.7, 14.1). Compared with adults who smoke daily, the proportion of past-year quit attempts was higher among people who reported smoking on some days of the month (always some days: 41.8%; formerly daily: 58.4%; daily: 32.2%). However, those who smoke some days were less likely to report receiving medical advice to quit (always some days: 49.5%; formerly daily: 58.1%; daily: 72.7%), using pharmacotherapy such as nicotine replacement therapy or a prescribed medication (always some days: 17.9%; formerly daily: 32.4%; daily: 38.7%), or receiving counseling to quit smoking (always some days: 5.8%; formerly daily: 6.9%; daily: 12.0%).

conclusionsGiven the substantial number of adults who smoke nondaily in the U.S. and their interest in quitting, developing targeted interventions and communication is an important public health priority.

Indexed as

Non-SmokersSmoking CessationTobacco Use Cessation DevicesAdolescentAdultAgedFemaleHumansMaleMiddle AgedUnited StatesYoung Adult

Identifiers

PMID39571835
PMCPMC11830521

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.